Affordable Access

deepdyve-link
Publisher Website

Key Articles and Guidelines in the Management of Dyslipidemia: 2019 Update.

Authors
  • Wiggins, Barbara S1
  • Dixon, Dave2
  • Bellone, Jessica3
  • Gasbarro, Nicole4
  • Marrs, Joel C5
  • Tran, Rebecca6
  • 1 Medical University of South Carolina, Charleston, SC, USA.
  • 2 15535Virginia Commonwealth University School of Pharmacy, Richmond, VA, USA.
  • 3 5269Sanofi US, Bridgewater Township, NJ, USA.
  • 4 1836Boston Medical Center, Boston, MA, USA.
  • 5 129263University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • 6 48927Keck Graduate Institute School of Pharmacy, Claremont, CA, USA.
Type
Published Article
Journal
Journal of pharmacy practice
Publication Date
Dec 01, 2020
Volume
33
Issue
6
Pages
882–894
Identifiers
DOI: 10.1177/0897190019868413
PMID: 31401932
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

Although the mortality from cardiovascular disease has declined, it remains the leading cause of morbidity and mortality in the United States. Dyslipidemia is a modifiable risk factor that plays a significant role in the development of atherosclerotic cardiovascular disease. Treating dyslipidemia by lowering cholesterol, predominately low-density lipoprotein cholesterol, has been shown to reduce cardiovascular events. The first article that provided dyslipidemia bibliographies was published in 2006. Since this time, new therapies have become available and older therapies that were once thought to provide benefit have since been shown to lack positive outcomes and have therefore fallen out of favor for routine use. As the body of evidence continues to expand, clinicians are faced with reevaluating their treatment strategies to ensure optimal outcomes and appropriate use of lipid-lowering therapies. Therefore, this compilation was created to serve as a resource for clinicians. This publication provides an update of key articles in dyslipidemia management including various guidelines and practice-changing randomized controlled trials.

Report this publication

Statistics

Seen <100 times